Warrant

LeddarTech Announces Adjustments to Warrant Exercise Price and Related Terms

Retrieved on: 
Wednesday, February 14, 2024

Corresponding adjustments will be made to the redemption provisions applicable to the Warrants.

Key Points: 
  • Corresponding adjustments will be made to the redemption provisions applicable to the Warrants.
  • The adjustments are effective as of the close of business on February 9, 2024.
  • The Prospector Share Dividend was not made with respect to any other Prospector or LeddarTech shares issued and outstanding prior to or upon consummation of the business combination.
  • Further information on the Warrants and the adjustment to the Warrant exercise price, including the U.S. Federal income tax treatment of this adjustment, is available in the "Investors" section of LeddarTech's website.

LeddarTech Announces Adjustments to Warrant Exercise Price and Related Terms

Retrieved on: 
Wednesday, February 14, 2024

Corresponding adjustments will be made to the redemption provisions applicable to the Warrants.

Key Points: 
  • Corresponding adjustments will be made to the redemption provisions applicable to the Warrants.
  • The adjustments are effective as of the close of business on February 9, 2024.
  • The Prospector Share Dividend was not made with respect to any other Prospector or LeddarTech shares issued and outstanding prior to or upon consummation of the business combination.
  • Further information on the Warrants and the adjustment to the Warrant exercise price, including the U.S. Federal income tax treatment of this adjustment, is available in the "Investors" section of LeddarTech's website.

Cosa Announces Upsized C$6.5 Million Bought Deal Private Placement to Fund Athabasca Basin Uranium Exploration

Retrieved on: 
Tuesday, February 13, 2024

VANCOUVER, British Columbia, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Cosa Resources Corp. (TSX-V: COSA) (OTCQB: COSAF) (FSE: SSKU) (“Cosa” or the “Company”) is pleased to announce that, in connection with its previously announced bought deal private placement offering (the “Offering”), it has entered into an amended agreement with Haywood Securities Inc., on behalf of itself and a syndicate of underwriters (collectively, the “Underwriters”) to increase the size of the Offering to: (i) 2,128,000 hard dollar units of the Company (the “Hard Dollar Units”) at a price of C$0.47 per Hard Dollar Unit (the “Hard Dollar Issue Price”), and (ii) 7,704,000 charity flow-through units of the Company (the “Charity FT Units”, and together with the Hard Dollar Units, the “Units”) at a price of C$0.714 per Charity FT Unit (the “Charity FT Issue Price”), for aggregate gross proceeds to the Company of C$6,500,816.

Key Points: 
  • Each Warrant will entitle the holder thereof to purchase one Share (a “Warrant Share”) at an exercise price of C$0.67 for 24 months following the completion of the Offering.
  • All Qualifying Expenditures will be renounced in favour of the subscribers of the Charity FT Units effective December 31, 2024.
  • The net proceeds from the sale of Hard Dollar Units will be used to fund exploration and for additional working capital purposes.
  • Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

Cosa Announces C$5 Million Bought Deal Private Placement To Fund Athabasca Basin Uranium Exploration

Retrieved on: 
Monday, February 12, 2024

VANCOUVER, British Columbia, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Cosa Resources Corp. (TSX-V: COSA) (OTCQB: COSAF) (FSE: SSKU) (“Cosa” or the “Company”) is pleased to announce that it has entered into an agreement with Haywood Securities Inc., on behalf of itself and a syndicate of underwriters (collectively, the “Underwriters”) who have agreed to purchase, or arrange for substitute purchasers, on a “bought deal” private placement basis, 2,128,000 hard dollar units of the Company (the “Hard Dollar Units”) at a price of C$0.47 per Hard Dollar Unit (the “Hard Dollar Issue Price”), and 5,603,000 charity flow-through units of the Company (the “Charity FT Units”, and together with the Hard Dollar Units, the “Units”) at a price of C$0.714 per Charity FT Unit (the “Charity FT Issue Price”), for aggregate gross proceeds to the Company of C$5,000,702 (collectively, the “Offering”).

Key Points: 
  • All Qualifying Expenditures will be renounced in favour of the subscribers of the Charity FT Units effective December 31, 2024.
  • The net proceeds from the sale of Hard Dollar Units will be used to fund exploration and for additional working capital purposes.
  • Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S.
  • Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

FuelPositive Announces Closing of Non-Brokered Private Placement

Retrieved on: 
Friday, February 9, 2024

Each Unit consists of one common share of the Company and one common share purchase warrant (each, a “Warrant”) allowing holders to purchase an additional common share at a price of $0.07 until February 9, 2029.

Key Points: 
  • Each Unit consists of one common share of the Company and one common share purchase warrant (each, a “Warrant”) allowing holders to purchase an additional common share at a price of $0.07 until February 9, 2029.
  • When combined with the first tranche of the Offering, the Company has raised gross proceeds of $1,897,905 through the issuance of 34,507,363 Units.
  • The net proceeds from the Offering will be utilized for general working capital purposes.
  • In connection with closing of the final tranche of the Offering, the Company issued 525,000 Warrants and paid $28,875 to certain arms-length parties who assisted in introducing subscribers to the Offering.

MedBright AI Announces Closing of LIFE Offering for Gross Proceeds of Approximately $1.4 Million

Retrieved on: 
Friday, February 9, 2024

Pursuant to the Offering, a total of 6,994,887 Units were sold at a price per Unit of $0.20 (the “Offering Price”).

Key Points: 
  • Pursuant to the Offering, a total of 6,994,887 Units were sold at a price per Unit of $0.20 (the “Offering Price”).
  • Each Unit consists of one common share of the Company (a “Share”) and one-half of one Share purchase warrant (each whole warrant, a “Warrant”).
  • The Offering has been conducted pursuant to the listed issuer financing exemption from prospectus requirements in Part 5A of National Instrument 45-106 – Prospectus Exemptions ("NI 45-106").
  • The Units, the Warrants and the Warrant Shares are not subject to resale restrictions pursuant to applicable Canadian securities laws.

Nine Mile Metals Private Placement Financing

Retrieved on: 
Thursday, February 8, 2024

VANCOUVER, British Columbia, Feb. 08, 2024 (GLOBE NEWSWIRE) -- NINE MILE METALS LTD. (CSE: NINE, OTCQB: VMSXF, FSE: KQ9) (the “Company” or “Nine Mile”) announces its intention to complete a private placement for proceeds of up to $500,000 (the “Private Placement”).

Key Points: 
  • VANCOUVER, British Columbia, Feb. 08, 2024 (GLOBE NEWSWIRE) -- NINE MILE METALS LTD. (CSE: NINE, OTCQB: VMSXF, FSE: KQ9) (the “Company” or “Nine Mile”) announces its intention to complete a private placement for proceeds of up to $500,000 (the “Private Placement”).
  • The Private Placement will consist of the sale of up to 8,333,333 units (each a “Unit”) at a price of $0.06 per Unit.
  • In consideration for their services in introducing subscribers to the Company under the Private Placement, finders may receive commission of 8% cash and 8% common share purchase warrants, exercisable to purchase one common share at a price of $0.10 for a period of 24 months.
  • All securities issued in the private placement will be subject to a four month and a day hold period.

ASTRALABS Under Andrew Ryan's Leadership Prevails in Final Newchip Warrant Sale Hearing

Retrieved on: 
Thursday, February 8, 2024

Parent Company of Newchip Accelerator, Prepares for Strategic Divestiture of $760M Warrant Portfolio, Charting a Renewed Path for Stakeholders

Key Points: 
  • 23-10164-smr, authorizing the unencumbered sale of its investment warrant portfolio, thereby releasing it from all liens, claims, and legal encumbrances.
  • This decisive judgment, quashing challenges to the sale of ASTRALABS' warrant asset portfolio, unequivocally affirms the company's adept strategic management and innovative handling of the Newchip warrants, marking the onset of a revitalized strategy aimed at enhancing creditor and investor returns.
  • This court's ruling represents a monumental victory for Newchip, ASTRALABS, and unequivocally validates our decisions as a leadership team.
  • This essential verdict facilitates a methodical sale of assets, dedicated to maximizing returns for all stakeholders and achieving the optimal sale value of ASTRALABS' portfolio holdings."

Optimi Announces Non-Brokered Private Placement

Retrieved on: 
Thursday, February 8, 2024

VANCOUVER, British Columbia, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a Health Canada licensed drug researcher and formulator specializing in controlled psychedelic substances such as natural psilocybin and MDMA, announces it intends to complete a non-brokered private placement of up to 5,000,000 units (each a “Unit”) at CAD$0.30 per Unit for gross proceeds of up to CAD$1,500,000 (the “Offering”).

Key Points: 
  • VANCOUVER, British Columbia, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a Health Canada licensed drug researcher and formulator specializing in controlled psychedelic substances such as natural psilocybin and MDMA, announces it intends to complete a non-brokered private placement of up to 5,000,000 units (each a “Unit”) at CAD$0.30 per Unit for gross proceeds of up to CAD$1,500,000 (the “Offering”).
  • Each Unit comprised of one (1) common share in the capital of the Company (each a "Common Share") and one-half of one (1/2) transferable Common Share purchase warrant (each whole warrant a “Warrant”).
  • It is anticipated that insiders of the Company may participate in the Offering for up to $605,000.
  • The Company intends to use the net proceeds from the Offering to obtain its Drug Establishment License, commercialization, and for general working capital.

DIH Holding US, Inc. Closes Business Combination with Aurora Technology Acquisition Corporation; Announces Updated Date for Commencement of Trading

Retrieved on: 
Wednesday, February 7, 2024

and SAN FRANCISCO, Feb. 07, 2024 (GLOBE NEWSWIRE) -- DIH Holding US, Inc., a leading global robotics and virtual reality (“VR”) technology provider in the rehabilitation and human performance industry, today announced that it has completed its business combination with Aurora Technology Acquisition Corp. (NASDAQ: ATAK) (“ATAK”), a publicly-traded special purpose acquisition company (“SPAC”).

Key Points: 
  • and SAN FRANCISCO, Feb. 07, 2024 (GLOBE NEWSWIRE) -- DIH Holding US, Inc., a leading global robotics and virtual reality (“VR”) technology provider in the rehabilitation and human performance industry, today announced that it has completed its business combination with Aurora Technology Acquisition Corp. (NASDAQ: ATAK) (“ATAK”), a publicly-traded special purpose acquisition company (“SPAC”).
  • DIH will use the cash from the business combination to grow a strategic market base and expand its position as the leading global provider of robotic and VR-enabled rehabilitation technology.
  • DIH’s Class A common stock and Warrants will begin trading on the Nasdaq Global Market (NasdaqGM) and Nasdaq Capital Market (NasdaqCM), respectively, on February 9, 2024.
  • Loeb & Loeb LLP is serving as legal counsel for DIH, and Dentons U.S. LLP is serving as legal counsel for ATAK.